Anthony Durkacz - HUGE Old Co-Chairman of the Board

HUGEDelisted Stock  USD 0.09  0  4.56%   

Chairman

Mr. Anthony Durkacz is CoChairman of the Board of the Company. He is currently a Director of FSD Pharma and a Director and Executive Vice President at First Republic Capital Corporationration since January 2014. First Republic Capital Corporationration acted as the exclusive agent of the Company and has raised approximately 53, 000, 000.00 of equity capital to date since 2018.
Age 48
Tenure 7 years
Professional MarksPh.D
Phone416 854 8884
Webhttps://www.fsdpharma.com
Durkacz holds an Honours Bachelor of Business Administration from Brock University with a major in both Accounting and Finance. He has vast experience in financing, mergers and acquisitions and structuring companies to go public. " I am honoured to be working alongside Dr. Raza, Zeeshan, the Board and everyone at the Company to assist with the acquisition of Therapix Biosciences Ltd. and with the execution of the Company exciting new growth strategy in the medicinal cannabis space.

HUGE Old Management Efficiency

The company has return on total asset (ROA) of (0.3374) % which means that it has lost $0.3374 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.6403) %, meaning that it created substantial loss on money invested by shareholders. HUGE Old's management efficiency ratios could be used to measure how well HUGE Old manages its routine affairs as well as how well it operates its assets and liabilities.
HUGE Old currently holds 337.46 K in liabilities with Debt to Equity (D/E) ratio of 0.01, which may suggest the company is not taking enough advantage from borrowing. HUGE Old has a current ratio of 3.9, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about HUGE Old's use of debt, we should always consider it together with its cash and equity.
FSD Pharma Inc., a biotechnology company, operates in the pharmaceutical research and development business. The company is also involved in the research and development of Lucid-Psych, a molecular compound identified for the treatment of mental health disorders and Lucid-MS, a molecular compound identified for the treatment of neurodegenerative disorders. FSD Pharma operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 10 people. HUGE Old (HUGE) is traded on NASDAQ Exchange in USA and employs 10 people.

Management Performance

HUGE Old Leadership Team

Elected by the shareholders, the HUGE Old's board of directors comprises two types of representatives: HUGE Old inside directors who are chosen from within the company, and outside directors, selected externally and held independent of HUGE. The board's role is to monitor HUGE Old's management team and ensure that shareholders' interests are well served. HUGE Old's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, HUGE Old's outside directors are responsible for providing unbiased perspectives on the board's policies.
Lakshmi Kotra, Chief Inc
Kevin Cassidy, Vice QualityLucid
Donal CPA, Chief Officer
Zeeshan Saeed, President Director
Dr BPHARM, CEO Director
Maryann Adesso, Corporate Secretary
Nathan CPA, Chief Officer
Andrzej MD, Vice Lucid
Anthony Durkacz, Co-Chairman of the Board
Randell Mack, President BioSciences

HUGE Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is HUGE Old a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.
You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.

Other Consideration for investing in HUGE Stock

If you are still planning to invest in HUGE Old check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the HUGE Old's history and understand the potential risks before investing.
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital